News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EBD Group Release: BioPharm America™ 2013 Program Leads with Plenary on Drug Development Pipeline “The Chameleon Rubik’s Cube”


6/7/2013 9:45:46 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON & CARLSBAD, Calif. & WASHINGTON--(BUSINESS WIRE)--EBD Group’s BioPharm America™ will kick off its 2013 program with an Opening Plenary entitled “Strategic R&D Planning: The Chameleon Rubik’s Cube” on Tuesday, September 17. The plenary features moderator Vaughn Kailian, Managing Director of MPM Capital and includes speakers James Hoyes, President of EMD Serono; David Meeker, CEO of Genzyme; and Roger Pomerantz, Senior VP and Head, Worldwide Licensing and Acquisitions at Merck. The panel will discuss long-term pipeline planning in drug development which can be likened to a Rubik’s cube that changes colors with its surroundings.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
EBD Group
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES